These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 11026044)

  • 1. [Genetic diagnosis of hereditary breast cancer].
    Yano K; Miki Y
    Nihon Rinsho; 2000 Apr; 58 Suppl():527-32. PubMed ID: 11026044
    [No Abstract]   [Full Text] [Related]  

  • 2. Lessons learned from BRCA1 and BRCA2.
    Zheng L; Li S; Boyer TG; Lee WH
    Oncogene; 2000 Dec; 19(53):6159-75. PubMed ID: 11156530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinicopathological characteristics of hereditary breast cancer].
    Ikeda N; Miyoshi Y; Noguchi S
    Nihon Rinsho; 2000 Apr; 58 Suppl():533-6. PubMed ID: 11026045
    [No Abstract]   [Full Text] [Related]  

  • 4. A breast/ovarian cancer patient with germline mutations in both BRCA1 and BRCA2.
    Ramus SJ; Friedman LS; Gayther SA; Ponder BA; Bobrow L; van der Looji M; Papp J; Olah E
    Nat Genet; 1997 Jan; 15(1):14-5. PubMed ID: 8988162
    [No Abstract]   [Full Text] [Related]  

  • 5. BRCA1 and BRCA2 are necessary for the transcription-coupled repair of the oxidative 8-oxoguanine lesion in human cells.
    Le Page F; Randrianarison V; Marot D; Cabannes J; Perricaudet M; Feunteun J; Sarasin A
    Cancer Res; 2000 Oct; 60(19):5548-52. PubMed ID: 11034101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are BRCA1- and BRCA2-associated breast cancers different?
    Offit K
    J Clin Oncol; 2000 Nov; 18(21 Suppl):104S-6S. PubMed ID: 11060336
    [No Abstract]   [Full Text] [Related]  

  • 7. [Roles of BRCA1 and BRCA2 in DNA repair and tumor suppression].
    Yano K; Miki Y
    Tanpakushitsu Kakusan Koso; 2001 Jun; 46(8 Suppl):1055-62. PubMed ID: 11436293
    [No Abstract]   [Full Text] [Related]  

  • 8. [Is hereditary predisposition to breast cancer linked to BRCA1 a disease of response to genotoxic lesions?].
    Feunteun J
    C R Seances Soc Biol Fil; 1998; 192(2):235-40. PubMed ID: 9759367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene-expression profiles in hereditary breast cancer.
    Sudbø J; Reith A; Lingjaerde OC
    N Engl J Med; 2001 Jun; 344(26):2029. PubMed ID: 11430338
    [No Abstract]   [Full Text] [Related]  

  • 10. The frequency of germ-line mutations in the breast cancer predisposition genes BRCA1 and BRCA2 in familial prostate cancer. The Cancer Research Campaign/British Prostate Group United Kingdom Familial Prostate Cancer Study Collaborators.
    Gayther SA; de Foy KA; Harrington P; Pharoah P; Dunsmuir WD; Edwards SM; Gillett C; Ardern-Jones A; Dearnaley DP; Easton DF; Ford D; Shearer RJ; Kirby RS; Dowe AL; Kelly J; Stratton MR; Ponder BA; Barnes D; Eeles RA
    Cancer Res; 2000 Aug; 60(16):4513-8. PubMed ID: 10969800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of ten novel and 13 recurring BRCA1 and BRCA2 germline mutations in Italian breast and/or ovarian carcinoma patients. Mutations in brief no. 178. Online.
    De Benedetti VM; Radice P; Pasini B; Stagi L; Pensotti V; Mondini P; Manoukian S; Conti A; Spatti G; Rilke F; Pierotti MA
    Hum Mutat; 1998; 12(3):215. PubMed ID: 10660329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. More on breast cancer guidelines.
    Nassar BA; Ludman MD; Costa MT; Welch JP; Butts CA; Love JR; Hogg H; Beis MJ
    CMAJ; 1998 Jun; 158(11):1429; author reply 1429-30. PubMed ID: 9629100
    [No Abstract]   [Full Text] [Related]  

  • 13. Differential contributions of BRCA1 and BRCA2 to early-onset breast cancer.
    Krainer M; Silva-Arrieta S; FitzGerald MG; Shimada A; Ishioka C; Kanamaru R; MacDonald DJ; Unsal H; Finkelstein DM; Bowcock A; Isselbacher KJ; Haber DA
    N Engl J Med; 1997 May; 336(20):1416-21. PubMed ID: 9145678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [BRCA1 and BRCA2--breast cancer susceptibility genes].
    Dagan E; Gershoni-Baruch R
    Harefuah; 1997 Nov; 133(10):455-7. PubMed ID: 9418320
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinicopathologic analysis of BRCA1- or BRCA2-associated hereditary breast carcinoma in Japanese women.
    Noguchi S; Kasugai T; Miki Y; Fukutomi T; Emi M; Nomizu T
    Cancer; 1999 May; 85(10):2200-5. PubMed ID: 10326698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Genetic alterations and DNA-based diagnosis in breast cancer].
    Matsumoto S; Emi M; Kasumi F; Nakamura Y
    Nihon Geka Gakkai Zasshi; 1996 May; 97(5):375-80. PubMed ID: 8709940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Founder BRCA1 mutations and two novel germline BRCA2 mutations in breast and/or ovarian cancer families from North-Eastern Poland.
    van Der Looij M; Wysocka B; Brozek I; Jassem J; Limon J; Olah E
    Hum Mutat; 2000 May; 15(5):480-1. PubMed ID: 10790213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A high occurrence of BRCA1 and BRCA2 mutations among Czech hereditary breast and breast-ovarian cancer families.
    Machácková E; Foretová L; Navrátilová M; Valík D; Claes K; Messiaen L
    Cas Lek Cesk; 2000 Oct; 139(20):635-7. PubMed ID: 11192759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modification of BRCA1- and BRCA2-associated breast cancer risk by AIB1 genotype and reproductive history.
    Rebbeck TR; Wang Y; Kantoff PW; Krithivas K; Neuhausen SL; Godwin AK; Daly MB; Narod SA; Brunet JS; Vesprini D; Garber JE; Lynch HT; Weber BL; Brown M
    Cancer Res; 2001 Jul; 61(14):5420-4. PubMed ID: 11454686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevention of familial breast cancers].
    Nomizu T; Ito K
    Nihon Rinsho; 2000 Apr; 58 Suppl():537-41. PubMed ID: 11026046
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.